The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling

Journal of Histochemistry and Cytochemistry

Volumn 49, Issue 2, 2001, Pages 237-246

  Solberg, H ^a   Ploug, M ^a   Hoyer Hansen G ^a   Nielsen, B S ^a   Lund, L R ^a  

^a FINSEN LABORATORY   (Denmark)

Author keywords

Cancer; Immunohistochemistry; Mouse; Tissue remodeling; UPAR

Indexed keywords

UROKINASE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CROSS LINKING; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEWIS CARCINOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR AFFINITY; TISSUE METABOLISM; TROPHOBLAST;

ANIMALIA; MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 0035147370     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540104900211     Document Type: Article

References (52)

1. Endotoxin stimulates expression of the murine urokinase receptor gene in vivo
2. The urokinase-type plasminogen activator system in cancer metastasis: A review
3. The receptor-binding site of urokinase
4. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis
5. The ligand binding domain of the cell surface receptor for urokinase-type plasminogen activator
6. 2-terminal amino acid sequence and glycosylation variants
7. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays
8. Urokinase plasminogen activator receptor, β2-integrins, and src-kinases within a single receptor complex of human monocytes
9. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
10. Prevention of metastasis by inhibition of the urokinase receptor
11. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion
12. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in hepatocellular carcinomas
13. Gene expression and function of the cellular receptor for u-PA (uPAR)
14. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes
15. Characterization of the cellular binding site for the urokinase-type plasminogen activator
16. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
17. Urokinase receptor and colorectal cancer survival
18. Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis
19. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer
20. Urokinase plasminogen activator cleaves its cellular receptor releasing the ligand-binding domain
21. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semi-quantitative PCR-based assay
22. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy
23. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract
24. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization
25. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
26. Lactational competance and involution of the mammary gland require plasminogen
27. 2 integrins in vivo
28. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngenic mice
29. A 55,000-60,000 receptor protein for urokinase-type plasminogen activator: Identification in human tumor cell lines and partial purification
30. Urokinase receptors in human monocytes
31. Identification and characterization of urokinase receptors in natural killer cells and T-cells-derived lymphokine activated killer cells
32. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue
33. Upregulation of urokinase receptor expression on migrating endothelial cells
34. Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta
35. The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils
36. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue
37. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for urokinase plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site
38. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only in the intact receptor
39. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria
40. Cellular receptor for urokinase plasminogen activator: Carboxylterminal processing and membrane anchoring by glycosyl-phosphatidylinositol
41. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
42. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer
43. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect
44. Cloning and expression of the receptor for human urokinase-plasminogen activator, a central molecule in cell-surface plasmin-dependent proteolysis
45. Differential expression of the receptor of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds
46. Expression of uPA and receptor by both neoplastic and stromal cells during xenograft invasion
47. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma
48. Identification and characterization of the murine cell surface receptor for the urokinase type plasminogen activator
49. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors
50. Expression and function of the urokinase-type plasminogen activator during mouse hemochorial placental development
51. Urokinase receptor antagonists discovery and application to in vivo models of tumor growth
52. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes